Cartesian Therapeutics Inc

Biotech Stocks Healthcare Stocks

$10.42

+0.78 (+8.09%)

As of Jun 30, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +290.2% upside

Low Target $22.44

Average Target $40.66

High Target $45.57

Current Price $10.42

Current
$10.42

Target
$40.66

$22.44 $40.66 avg $45.57

Scenario Analysis

Bear Case

$22.44

115.4%

Low target

Base Case

$40.66

+290.2%

Avg target

Bull Case

$45.57

+337.3%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$15.57

-33.1% from high

52-Week Low

$5.60

+86.1% from low

Target vs 52W High

$40.66

+161.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%